Cenobamate: New Antiseizure Medication with High Efficacy
Received Date: October 18, 2021; Published Date: November 17, 2021
Approximately 30% of epilepsy patients experience recurrent seizures despite many new antiseizure medications (ASMs) became available over the past 25 years. Cenobamate is a newest FDA approved ASM for the treatment of focal onset seizures in adults as both monotherapy and adjunctive therapy in November 2019 . Pivotal clinical trials reported superior seizure improvement in patients with focal epilepsy.